Afsaneh Keyhani

763 total citations
18 papers, 601 citations indexed

About

Afsaneh Keyhani is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Afsaneh Keyhani has authored 18 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Afsaneh Keyhani's work include Bladder and Urothelial Cancer Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer Research and Treatments (3 papers). Afsaneh Keyhani is often cited by papers focused on Bladder and Urothelial Cancer Treatments (4 papers), Acute Myeloid Leukemia Research (3 papers) and Cancer Research and Treatments (3 papers). Afsaneh Keyhani collaborates with scholars based in United States, Iran and Japan. Afsaneh Keyhani's co-authors include Lance C. Pagliaro, Gabriel Lopez‐Berestein, Emil J. Freireich, R T Mehta, Paul Perrotte, Kishor M. Wasan, Colin P. Dinney, Gayle A. Brazeau, Teresa McQueen and Denise M. Woods and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Afsaneh Keyhani

18 papers receiving 584 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Afsaneh Keyhani United States 15 222 132 108 106 84 18 601
Yongdong Liu China 17 345 1.6× 131 1.0× 114 1.1× 74 0.7× 48 0.6× 64 882
Marco Antonio Leyva‐Vázquez Mexico 18 435 2.0× 110 0.8× 54 0.5× 104 1.0× 101 1.2× 65 882
Daniela Pintérová Czechia 11 166 0.7× 91 0.7× 31 0.3× 82 0.8× 80 1.0× 18 503
N Génetet France 18 261 1.2× 205 1.6× 140 1.3× 81 0.8× 76 0.9× 54 1.0k
Hermann Erich Karges Germany 15 188 0.8× 48 0.4× 146 1.4× 54 0.5× 49 0.6× 34 647
Blaire L. Osborn United States 14 379 1.7× 130 1.0× 58 0.5× 36 0.3× 53 0.6× 26 830
L O Hedén Sweden 16 333 1.5× 62 0.5× 87 0.8× 60 0.6× 61 0.7× 20 1.0k
Laurie Sower United States 13 340 1.5× 50 0.4× 204 1.9× 40 0.4× 91 1.1× 19 782
R. N. Taub United States 15 235 1.1× 206 1.6× 36 0.3× 127 1.2× 92 1.1× 35 819
Alton L. Melton United States 12 175 0.8× 87 0.7× 45 0.4× 29 0.3× 123 1.5× 25 754

Countries citing papers authored by Afsaneh Keyhani

Since Specialization
Citations

This map shows the geographic impact of Afsaneh Keyhani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afsaneh Keyhani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afsaneh Keyhani more than expected).

Fields of papers citing papers by Afsaneh Keyhani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afsaneh Keyhani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afsaneh Keyhani. The network helps show where Afsaneh Keyhani may publish in the future.

Co-authorship network of co-authors of Afsaneh Keyhani

This figure shows the co-authorship network connecting the top 25 collaborators of Afsaneh Keyhani. A scholar is included among the top collaborators of Afsaneh Keyhani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afsaneh Keyhani. Afsaneh Keyhani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Oshiro, Hisashi, Bogdan Czerniak, Kentaro Sakamaki, et al.. (2016). Comparison between whole mount tissue preparations and virtual tissue microarray samples for measuring Ki-67 and apoptosis indices in human bladder cancer. Medicine. 95(31). e4500–e4500. 2 indexed citations
2.
Sahebjamee, Mahnaz, et al.. (2009). Human papillomavirus in saliva of patients with oral squamous cell carcinoma. Medicina oral, patología oral y cirugía bucal. 14(10). e525–e528. 41 indexed citations
4.
Pearlman, Michael, Lance C. Pagliaro, Afsaneh Keyhani, et al.. (2003). Dexrazoxane's protection of jejunal crypt cells in the jejunum of C3Hf/Kam mice from doxorubicin-induced toxicity. Cancer Chemotherapy and Pharmacology. 52(6). 477–481. 6 indexed citations
5.
Pagliaro, Lance C., Afsaneh Keyhani, Baoshun Liu, et al.. (2003). Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin. Urologic Oncology Seminars and Original Investigations. 21(6). 456–462. 36 indexed citations
6.
Pearlman, Michael, et al.. (2003). Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines. Leukemia Research. 27(7). 617–626. 24 indexed citations
7.
Pagliaro, Lance C., Afsaneh Keyhani, Dallas Williams, et al.. (2003). Repeated Intravesical Instillations of an Adenoviral Vector in Patients With Locally Advanced Bladder Cancer: A Phase I Study of p53 Gene Therapy. Journal of Clinical Oncology. 21(12). 2247–2253. 99 indexed citations
8.
Klostergaard, Jim, et al.. (2002). Effective cytotoxicity against human leukemias and chemotherapy-resistant leukemia cell lines by N-N-dimethylsphingosine. Leukemia Research. 26(3). 301–310. 24 indexed citations
9.
Keyhani, Afsaneh, et al.. (2001). Angiogenesis and leukemia. Leukemia Research. 25(8). 639–645. 24 indexed citations
10.
Keyhani, Afsaneh, Yang O. Huh, Lance C. Pagliaro, et al.. (2000). Increased CD38 expression is associated with favorable prognosis in adult acute leukemia. Leukemia Research. 24(2). 153–159. 54 indexed citations
11.
Engel, Heike, Johannes Drach, Afsaneh Keyhani, et al.. (1999). Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells. Leukemia. 13(4). 568–577. 25 indexed citations
12.
Keyhani, Afsaneh, et al.. (1998). Multilineage involvement of Philadelphia chromosome positive acute lymphoblastic leukemia. Leukemia. 12(5). 666–674. 32 indexed citations
13.
Engel, Heike, Angela Goodacre, Afsaneh Keyhani, et al.. (1997). Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow‐up of patients in clinical remission. British Journal of Haematology. 99(1). 64–75. 20 indexed citations
14.
Mehta, R T, Teresa McQueen, Afsaneh Keyhani, & Gabriel Lopez‐Berestein. (1994). Phagocyte Transport as Mechanism for Enhanced Therapeutic Activity of Liposomal Amphotericin B. Chemotherapy. 40(4). 256–264. 31 indexed citations
15.
Wasan, Kishor M., et al.. (1993). Roles of liposome composition and temperature in distribution of amphotericin B in serum lipoproteins. Antimicrobial Agents and Chemotherapy. 37(2). 246–250. 77 indexed citations
16.
Mehta, R T, et al.. (1993). In vitro activities of free and liposomal drugs against Mycobacterium avium-M. intracellulare complex and M. tuberculosis. Antimicrobial Agents and Chemotherapy. 37(12). 2584–2587. 45 indexed citations
17.
Mehta, R T, Teresa McQueen, Afsaneh Keyhani, & Gabriel Lopez‐Berestein. (1991). Liposomal Hamycin: Reduced Toxicity and Improved Antifungal Efficacy In Vitro and In Vivo. The Journal of Infectious Diseases. 164(5). 1003–1006. 17 indexed citations
18.
Wasan, Kishor M., Kiumars Vadiei, David R. Luke, et al.. (1991). Antifungal activity of HWA-138 and amphotericin B in experimental systemic candidiasis. Antimicrobial Agents and Chemotherapy. 35(10). 2046–2048. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026